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Abstract
Background: The reported success rates for treatments of kidney stones with either extracorporeal shock wave lithotripsy
(ESWL) or flexible ureterorenoscopy (URS) are conflicting. We aimed to compare the efficacy and safety of ESWL and URS for
previously untreated renal calculi.
Methods: All patients treated with ESWL or URS at our tertiary care centre between 2003 and 2015 were retrospectively
identified. Patients with previously untreated kidney stones and a stone diameter of 5–20 mm were included. Stone-free,
freedom from reintervention and complication rates were recorded. Independent predictors of stone-free and freedom from
reintervention rates were identified by multivariable logistic regression and a propensity score-matched analysis was performed.
Results: A total of 1282 patients met the inclusion criteria, of whom 999 (78%) underwent ESWL and 283 (22%) had URS.
During post-operative follow-up, only treatment modality and stone size could independently predict stone-free and
freedom from reintervention rates. After propensity score matching, ESWL showed significantly lower stone-free rates
[ESWL (71%) versus URS (84%)] and fewer patients with freedom from reintervention [ESWL (55%) versus URS (79%)] than
URS. Complications were scarce for both treatments and included Clavien Grade 3a in 0.8% versus 0% and Grade 3b in 0.5%
versus 0.4% of ESWL and URS treated patients, respectively.
Conclusions: Treatment success was mainly dependent on stone size and treatment modality. URS might be the better
treatment option for previously untreated kidney stones 5–20 mm, with similar morbidity but higher stone-free rates and
fewer reinterventions than ESWL.
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Introduction
Urolithiasis is a common disease, representing a relevant public
health problem worldwide with a prevalence of 8.8% in the USA
and annual health care costs of USD 3.8 billion [1–3]. Although
kidney stones initially often remain asymptomatic, treatment is
frequently performed to prevent future problems associated with
the disease (e.g. renal colic, urinary tract infections and impair-
ment of kidney function) [4]. Treatment for kidney stones should
achieve both high stone-free rates and low complication rates.
Extracorporeal shock wave lithotripsy (ESWL) and flexible ureter-
orenoscopy (URS) are nowadays the most commonly used treat-
ment options for kidney stones<20 mm. ESWL was introduced in
the 1980s [5] and quickly became the gold standard for the treat-
ment of kidney stones [6, 7]. In the 1990s, URS emerged with the
advantages of direct visualization and extraction of kidney calculi
[8–10]. Currently, the American Urological Association guideline
recommends ESWL or URS as equivalent first-line interventions
for the treatment of kidney stones< 20 mm [11]. The guidelines of
the European Association of Urology (EAU) additionally distin-
guish between lower pole and non-lower pole kidney stones.
They recommend both treatments as equivalent options for kid-
ney stones of 10–20 mm, but favour URS for lower pole stones if
adverse factors (such as anatomy and stone composition) argue
against ESWL [4].
A recent meta-analysis including several randomized con-
trolled trials (RCTs) demonstrated a superior treatment success
of URS over ESWL when treating lower pole kidney stones [10].
However, evidence regarding optimal treatment of non-lower
pole kidney stones is scarce. In this study, we aimed to compare
success and complication rates of ESWL and URS in a large
cohort of patients with previously untreated lower or non-lower
pole kidney stones of 5–20 mm in size.
Materials and methods
We retrospectively identified patients with kidney stones treated
with ESWL or URS at our tertiary care centre between 2003 and
2014. Treatment method was chosen according to the surgeon’s
and patient’s preferences. Patients with previously untreated kid-
ney stones and a stone diameter of 5–20 mm were included.
Patients with further untreated kidney stones on the contrala-
teral side were included a second time if a treatment was per-
formed. Patients with new onset of nephrolithiasis but with a
previous history of kidney stones were only included if they were
stone-free for at least 12 months. The study was approved by the
local ethics committee (STV KEK-ZH 2014-0198).
Pretreatment stone size and location were generally
assessed by ultrasonography (US) and radiological examination
[X-ray and or non-contrast computed tomography (CT) of the
abdomen]. The following preoperative parameters for each
patient were noted: age, gender, body mass index (BMI), stone
size, number of stones and stone location (upper calyx, middle
calyx, lower calyx, pelvis or multiple locations). All periopera-
tive complications until discharge were assessed using the
Clavien–Dindo grading system [12].
Success rate after intervention was assessed by stone-free
and freedom from reintervention rates. As primary endpoint,
we assessed stone-free rates for each treatment method during
follow-up using X-ray, US or CT. Stone-free was defined as stone
clearance during postinterventional follow-up without any
residual fragments>2 mm in the kidney. Retreatment for resid-
ual stones was recorded during follow-up and freedom from
reintervention was chosen as secondary endpoint. Freedom
from reintervention was defined as no need of secondary inter-
vention for residual stone(s) after primary treatment.
ESWL was performed under general or regional anaesthesia
depending on patient’s preference. The exact stone location
was identified by X-ray and/or US at baseline and verified regu-
larly during ESWL treatment. In general, a maximum of 3000
shock waves were applied to the kidney stone(s) or fewer if
complete stone disintegration was observed before. In case of
double J ureter stenting during ESWL, the stent normally
remained for 4–6 weeks or longer depending on the clinical
course. Two different lithotripters were used during the study
period: from the start of the study until September 2007, the
ESWL treatments were performed on a Dornier DL50 lithotripter
(Dornier MedTech, Wessling, Germany). Subsequently, a
Dornier DLS II (Dornier MedTech) was in operation from
September 2007 until the end of this study.
URS was conducted under general or regional anaesthesia
depending on patient’s preference. The choice between primary
and secondary URS (double J ureter stent 7–14 days before sur-
gery) was based on the surgeon’s preference. A flexible URS was
introduced for direct vision of the collecting kidney system after
insertion of a ureteral access sheet. Irrigation was performed
using a roller-pump mechanical irrigation device (Uromat; Karl
Storz, Culver City, CA, USA) and intrarenal pressure levels rang-
ing from 100 to 200 mmHg, depending on the individual intrare-
nal anatomy and visibility.
Stone fragmentation, if required, was performed using a hol-
mium: YAG laser. Calculi and fragmented stones were extracted
using a stone basket. At the end of the procedure, the ureteral
mucosa was reinspected to identify any potential damage or
perforation and all patients received a double J ureter stent for
3–10 days.
Independent predictors of stone-free and freedom from rein-
tervention rates were identified by multivariable analysis using
logistic regression including the following covariates: age, gen-
der, BMI, largest stone size and number of stones. Odds ratios
(ORs) with 95% confidence intervals (CIs) were calculated. To
assess whether one of the two lithotripters showed relevant dif-
ferences in stone-free and freedom from reintervention rates,
we compared both endpoints for each lithotripter in a sensitiv-
ity analysis.
We analysed a propensity score-matched sample from all
included patients to limit the observational character of the
study. For the computation of the propensity score, the following
variables were included into a non-parsimonious logistic regres-
sion with ESWL/URS as dependent variable: age, gender, BMI,
stone size and number of stones. Missing values were replaced
by multiple regression imputation for the respective analysis.
The validity of the logistic regression was assessed using the
Hosmer–Lemeshow test.
Statistical analysis was performed with IBM SPSS Statistics
(Version 21.0; IBM Corp., Armonk, New York, USA). Propensity
score matching was performed using R programming language
and software environment version 3.1.3 (R Foundation for
Statistical Computing, Vienna, Austria) using the package
Matching in R [13]. The results for continuous normally distrib-
uted variables are expressed as means6 standard deviation
(SD) and differences in patient characteristics between two
groups were compared using Student’s unpaired t-test.
Continuous non-normally distributed variables are presented
as median and interquartile ranges (IQR) and analysed using
the Mann–Whitney U test. The results for categorical variables
are presented as percentage analysed using Fisher’s exact test
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or chi-square test whenever appropriate. A P-value of<0.05 was
considered significant. All statistical tests were two-sided.
Results
Of the 1282 patients included in our study, 999 (78%) underwent
ESWL and 283 (22%) had URS for primary treatment of kidney
stones. A primary URS was conducted in 154/283 patients
(54.4%), whereas in 129/283 cases (45.6%), a secondary URS was
performed. Patient baseline characteristics partitioned into
ESWL and URS patients as well as the propensity score-
matched populations are shown in Table 1.
Patients treated with ESWL and URS showed comparable char-
acteristics for age, BMI and gender, but significantly differed
regarding median stone size [ESWL versus URS, 9 (IQR 7–11) versus
8 (IQR 6–11), P< 0.001] and number of stones (P< 0.001) (Table 1).
The only independent predictors for stone-free rate as
defined by multivariable regression analysis were the treatment
modality [ESWL versus URS; OR 0.421 (95% CI 0.267–0.662),
P< 0.001] and the stone size [OR 0.850 (95% CI 0.840–0.920),
P< 0.001] (Table 2). The same parameters were also independ-
ent predictors for lower freedom from reintervention [choice of
treatment: ESWL versus URS; OR 0.340 (95% CI 0.203–0.571),
P< 0.001; and stone size; OR 0.797 (95% CI 0.751–0.845),
P< 0.001]. Our sensitivity analysis for the two different ESWL
lithotripters revealed no significant difference in stone-free
(4.2%, 95% CI 1.0 to 1.6, P¼ 0.16) and freedom from reinter-
vention rates (4.3%, 95% CI 11.5 to 2.9, P¼ 0.26). A visual anal-
ysis of stone-free rate over the whole study period confirmed
similar results for both lithotripters (Supplementary data,
Figure S1).
A 2:1 propensity score matching showed an adequate level of
calibration (Hosmer–Lemeshow test: P¼ 0.322). After propensity
Table 1. Patient characteristics of all patients and the propensity score-matched cohort
All (n51282) Propensity score 2:1 matched (n5735)
ESWL URS P-value ESWL URS P-value
Number of patients (%) 999 (78) 283 (22) 490 (67) 245 (33)
Age, years (6SD) 49 (15.0) 51 (14.4) 0.124 50 (15.0) 51 (14.2) 0.685
Female (%) 274 (27.4) 74 (26.1) 0.669 126 (25.7) 71 (29.0) 0.346
Male (%) 725 (72.6) 209 (73.9) 364 (74.3) 174 (71.0)
BMI, kg/m2 (6SD) 27 (4.75) 27 (4.64) 0.596 27 (4.4) 27 (4.9) 0.790
Size of biggest stone, mm (IQR) 9 (7–11) 8 (6–11) <0.001 8 (6–10) 8 (6–12) 0.988
Number of stones (%) <0.001 0.722
1 49 51 57 58
2 15 25 26 22
3 7 13 11 11
>3 4 11 5 9
Complications (%)
Clavien II 24 (2.4) 20 (7.1) <0.001 17 (3.5) 17 (6.9) <0.001
Clavien IIIa 8 (0.8) 0 (0) 0.21 3 (0.6) 0 (0)
Clavien IIIb 5 (0.5) 1 (0.4) 0.30 3 (0.6) 1 (0.4)
Clavien IV 0 0 0 (0) 0 (0)
Bold P-values indicate statistical significance.
Table 2. Multivariable logistic regression analysis evaluating predictors for (A) stone-free and (B) freedom from reintervention rates after pri-
mary treatment for nephrolithiasis
Bold P-values indicate statistical significance.
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score matching, the ESWL group consisted of 490 and the URS
group of 245 patients. The matching successfully eliminated the
significant differences in median stone size (P¼ 0.988) and in
number of stones (P¼ 0.722) (Table 1). However, the two treat-
ment modalities still showed significant differences regarding
stone-free [ESWL 350/490 (71%) versus URS 206/245 (84%),
P< 0.001] and freedom from reintervention rates [ESWL 199/361
(55%) versus URS 133/168 (79%), versus P< 0.001] (Figure 1).
In a subgroup analysis, the patients with non-lower pole
stones treated with ESWL showed a significantly lower stone-
free rate [ESWL 251/368 (68.2%) versus URS 131/159 (82.4%),
P< 0.001] as well as a lower freedom from reintervention rate
[ESWL 145/276 (52.5%) versus URS 98/127 (77.2%), P< 0.001]
compared with the patients treated with URS. The subgroup
analysis of lower pole stones revealed nonsignificantly lower
stone-free rates after ESWL treatments [ESWL 89/111 (80.2%)
versus URS 40/45 (88.9%), P¼ 0.246] but a significantly lower
freedom from reintervention rate [ESWL 53/84 (61.1%) versus
URS 33/36 (91.7%), P¼ 0.002] than after URS treatments.
Only very few relevant perioperative complications for both
treatment modalities were recorded. After ESWL, 24 (2.4%)
Grade II complications including 22 urinary tract infections
(UTIs), one patient with urinary retention and one patient with
strong urge to void was recorded. Additionally, 13 out of 999
(1.3%) patients had a Grade IIIa or IIIb complication. Among
these, 12 patients were diagnosed with painful ureteral obstruc-
tions due to passing fragments and subsequently underwent
transurethral stent insertion. Angiography was performed in
one patient with a renal haematoma after ESWL. No active
bleeding was observed and the angiography was terminated
without coiling placement. In the URS group, 20 (7.1%) Grade II
complications including 18 UTIs and 2 atrial fibrillations were
observed. One patient (0.4%) needed a transurethral stent repo-
sition because of stent migration (Grade IIIb complication). We
did not observe any Grade 4 (life-threatening) complication for
either intervention (Table 1).
Discussion
The present study aimed to investigate and compare the treat-
ment success of ESWL and URS in a large cohort of patients
with untreated renal stones of 5–20 mm in size. Our study
revealed that ESWL was less effective than URS for the treat-
ment of kidney calculi. Treatment modality (in favour of URS)
and stone size were the only independent predictors for stone-
free and freedom from reintervention rates. After propensity
score matching, ESWL showed significantly lower stone-free
rates and fewer patients with freedom from reintervention
compared with URS.
Our findings are consistent with, and extend those of, prior
reports. To date, the efficacy and safety of URS compared with
ESWL has been evaluated in a few RCTs and several cohort
studies. Recently, five RCTs and two out of three meta-analyses
confirmed the superiority of URS in patients with lower pole
kidney stones [8–10, 14–17]. For non-lower pole kidney stones,
however, only limited evidence exists. Only two RCTs included
non-lower pole stones. The first study failed to accrue a suffi-
cient number of patients [18]. The second RCT included only 46
obese patients and showed a significantly higher stone-free rate
in the URS group (90.4% versus 68%) [19]. The low number of
patients and/or patient selection limits the validity for both
studies. Thus, the available RCTs are inconclusive regarding
treatment of non-lower pole stones.
Additionally, several cohort studies proposed the superiority
of URS; however, they showed some evident limitations due to
the nature of their study design [20–27]. Most of these retrospec-
tive cohort studies were small (with a mean of 162 patients) and
no statistical methods to control for confounders were applied.
To the best of our knowledge, our study including over 1200
patients is the largest retrospective study comparing the suc-
cess rates of ESWL and URS for untreated renal calculi.
Moreover, it is the first non-randomized cohort study that fac-
tors in known confounders such as age, sex, BMI, stone size and
number of stones.
In our study, URS showed significantly better treatment suc-
cess, which is reflected by higher stone-free and freedom from
reintervention rate in comparison with ESWL. However, the
higher stone-free rate after URS would be less game-changing if
associated with distinctly higher rates of morbidity. As URS is
considered as more invasive than ESWL, the assessment of
treatment morbidity is crucial for further comparison of both
interventions. In our large cohort study, we found a similarly
low perioperative morbidity with very few relevant complica-
tions (Clavien Grade IIIa or IIIb complications) in both interven-
tion groups. Our data confirmed that both interventions (ESWL
and URS) are safe procedures, which is in line with previously
published work [8–10, 14–17, 20–27].
The most common complications in our cohort were UTIs. In
our cohort, 2.2% of all patients undergoing ESWL were diagnosed
with a UTI, which is comparable to other series ranging from 0.5
to 2.5% [28–30]. Similarly, UTIs were found in 6.4% of all URS
patients, which is comparable to previously published cohorts
Fig. 1. (A) Stone-free and (B) intervention-free rates for ESWL and URS in the pro-
pensity score-matched cohort.
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reporting UTI rates ranging from around 7.4 to 7.7% [31, 32]. This
highlights the importance of preoperative urine cultures, which
should be performed several days ahead of the procedure.
Whereas for ESWL, the EAU guidelines recommend to prescribe
perioperative antibiotics only in patients with infected stones or
bacteriuria, it is recommended to give perioperative antibiotics to
every patient before undergoing URS [4]. However, it remains chal-
lenging to choose the right antibiotic and to identify patients at
risk for postoperative UTIs because of the poor correlation
between voided urine and stone cultures [33].
The second most common complication in the ESWL group
represented ureter obstruction caused by passing stones and the
need for stent placement. In our cohort, 12 (1.2%) patients needed
a stent placement due to obstructing ureter stones, which is
slightly lower compared with previously described cohorts rang-
ing from 4 to 8% [34, 35]. A potential explanation may include the
inpatient management at our institution allowing an intensified
pain management. Our most severe complication included a hae-
modynamically relevant renal haematoma post ESWL for which
the patient underwent angiography. At the time of angiography,
no active bleeding was identified and thus no coiling was per-
formed. Symptomatic haematoma represents a feared complica-
tion but has been reported in <1% of all patients [36, 37].
Our results must be interpreted in the context of the retro-
spective study design. Because of the observational study
design potential selection, misclassification and information
bias may have occurred. Although the study was controlled for
known confounders, residual confounding by disregarded or
unknown variables may still have occurred. US and X-ray have
limited accuracy in detecting residual stones after treatment,
which might have resulted in an overestimation of stone-free
rate in the current study. As even clinically insignificant resid-
ual stones affect recurrence rates [38], freedom from reinterven-
tion might be a superior endpoint for the assessment of efficacy
in stone treatment. In our study, URS resulted in distinctly more
patients with freedom from reintervention compared with
ESWL. Another limitation is that we are not able to report long-
term complications.
The varying stone-free rate observed after ESWL during our
study period indicates that additional factors (i.e. detailed and
specific settings of the lithotripter, experience of treating physi-
cian) are important for successful ESWL treatments. The impor-
tance of a comprehensive understanding not only of the
pathophysiology, but also of shock wave physics in order to
facilitate a successful ESWL treatment has already been demon-
strated in previous work [39].
In this study, we present one of the largest reported cohorts
for comparison of ESWL and URS for primary stone treatment.
Besides the assessment of efficacy of treatment, we also
analysed the complication rates and found them to be equally
low for both treatment groups. This observation is of impor-
tance, as large cohort studies are more likely to detect differen-
ces in complication rates between treatments than smaller
cohorts or even RCTs. In the absence of RCTs for non-lower pole
kidney stones, this study is the largest comparative study of
treatment efficacy and safety between ESWL and URS, providing
evidence that URS might be the better treatment option in
untreated kidney stones up to 20 mm in size.
Supplementary data
Supplementary data are available at ckj online.
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